{"id":96236,"date":"2026-06-09T17:45:49","date_gmt":"2026-06-09T17:45:49","guid":{"rendered":"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/"},"modified":"2026-06-09T17:45:49","modified_gmt":"2026-06-09T17:45:49","slug":"david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition","status":"publish","type":"post","link":"https:\/\/youzum.net\/es\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/","title":{"rendered":"David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition"},"content":{"rendered":"<div data-chronoton-summary=\"&lt;ul&gt;&lt;br&gt;&lt;li&gt;&lt;strong&gt;A bold new bet on whole-body rejuvenation:&lt;\/strong&gt; Harvard biologist David Sinclair plans to test an oral &quot;reprogramming&quot; drug on human volunteers as part of a $101 million XPrize competition.&lt;\/li&gt;&lt;br&gt;&lt;li&gt;&lt;strong&gt;Chemicals instead of gene therapy:&lt;\/strong&gt; Sinclair's new drug candidate \u2014 code-named SL-100 \u2014 uses drugs to mimic the effects of reprogramming genes, and will attempt to reset aging across the body.&lt;\/li&gt;&lt;br&gt;&lt;li&gt;&lt;strong&gt;Experts urge caution:&lt;\/strong&gt; Other scientists warn that chemical reprogramming efforts have so far proven either ineffective at low doses or outright toxic at high ones \u2014 and Sinclair's unpublished animal data has yet to face outside scrutiny.&lt;\/li&gt;&lt;br&gt;&lt;li&gt;&lt;strong&gt;The field's bigger problem:&lt;\/strong&gt; Scientists still can't agree on how to reliably measure aging or age reversal, making the XPrize competition as much about establishing scientific standards as it is about crowning a winner.&lt;\/li&gt;&lt;\/ul&gt;\" data-chronoton-post-id=\"1138545\" data-chronoton-expand-collapse=\"1\" data-chronoton-analytics-enabled=\"1\"><\/div>\n<p>The outspoken longevity scientist David Sinclair has been predicting that one day, you\u2019ll go to the doctor and get a prescription that will make you 10 years younger.<\/p>\n<p>Now <em>MIT Technology Review<\/em> has learned that he has plans to launch human tests of an oral \u201creprogramming\u201d drug as part of a $101 million <a href=\"https:\/\/www.xprize.org\/competitions\/healthspan\">competition<\/a> organized by the XPrize Foundation.\u00a0<\/p>\n<p>The foundation is offering cash awards to teams able to \u201crestore\u201d a person to an earlier apparent age, as measured by improvements in immune, cognitive, and muscle function.\u00a0<\/p>\n<p>The grand prize goes to any team able to show a 10-year (or greater) relative improvement after one year of treatment.\u00a0<\/p>\n<p>Reached by phone, Sinclair, a biologist at Harvard Medical School, confirmed that he plans to give an oral drug mixture to volunteers in a bid to seek \u201cevidence for age restoration in humans.\u201d<\/p>\n<p>The trial, if it goes forward, will be a significant new development in the race to harness so-called epigenetic reprogramming. That technology is based on the discovery, 20 years ago, of powerful genes able to turn an adult cell into a stem cell similar to those found in embryos.<\/p>\n<p>The age-reversal effect is believed to occur via a resetting of molecular controls on DNA known as epigenetic marks, which help determine a cell\u2019s overall metabolism and identity.<\/p>\n<p>Companies are now racing to use that phenomenon for a new form of rejuvenation medicine. Only this January, one of Sinclair\u2019s companies, <a href=\"https:\/\/www.technologyreview.com\/2026\/01\/27\/1131796\/the-first-human-test-of-a-rejuvenation-method-will-begin-shortly\/\">Life Biosciences<\/a>, made news by winning approval to launch an initial human trial using a set of powerful reprogramming genes. The company announced today it had treated its first patient.\u00a0<\/p>\n<p>But that test involves a <a href=\"https:\/\/www.technologyreview.com\/2026\/01\/27\/1131796\/the-first-human-test-of-a-rejuvenation-method-will-begin-shortly\/\">complex gene therapy<\/a> and is limited to patients\u2019 eyes, where it could treat conditions like glaucoma.\u00a0<\/p>\n<p>Sinclair\u2019s new plan is bolder: a reprogramming drug you\u2019d swallow in order to promote such effects across the body.\u00a0<\/p>\n<p>\u201cWhat we\u2019re aiming to do is to epigenetically restore the animal and eventually the person,\u201d he says. \u201cIt is true that we\u2019ve been doing extensive animal studies with the oral agent and are looking to compete in the XPrize.\u201d<\/p>\n<p>This alternative method, chemical reprogramming, uses drugs to mimic the effects of the embryonic genes. That is significant because drug compounds can travel through the bloodstream, reaching most or all cells in a person\u2019s body.\u00a0<\/p>\n<p>Some experts expressed caution, saying the chemical process, at least as used in labs, is extremely harsh and not even particularly effective. \u201cWho doesn\u2019t dream of whole-body rejuvenation? I think it\u2019s a great goal,\u201d says Sergiy Velychko, founder of Soxogen, a stealth reprogramming company in Boston. \u201cBut these chemicals are used in very, very high concentrations for cell reprogramming.\u201d<\/p>\n<p>Sinclair declined to describe the exact makeup of the drug candidate, code-named SL-100, calling its contents \u201chighly, highly confidential.\u201d<\/p>\n<p>However, he has previously published lab studies of what he called \u201cepigenetic age-reversal cocktails,\u201d which mixed powerful chemicals with known supplements and commercially available medicines.\u00a0<\/p>\n<p>It\u2019s those latter components that would be easiest to test on people, since doctors are free to prescribe them, even for unusual objectives like age reversal. <a href=\"https:\/\/www.technologyreview.com\/2019\/08\/16\/133364\/transhumanists-live-forever\/\">James Clement<\/a>, head of Betterhumans, an organization that specializes in life-extension studies using existing drugs, said in a message that he is \u201crunning clinical trials\u201d of an oral reprogramming cocktail for Sinclair\u2019s XPrize team.<\/p>\n<p>Sinclair\u2019s team is competing in the <a href=\"https:\/\/www.technologyreview.com\/2023\/11\/29\/1084052\/x-prize-aging-101-million-award\/\">XPrize Healthspan Competition<\/a>, launched in 2023. It follows several previous competitions that focused on commercial spaceflight, lunar landings, and other goals. The XPrize Foundation is led by executive chairman Peter Diamandis, also an active promoter of longevity research.<\/p>\n<p>\u201cIf two teams are equivalent, they would split the award,\u201d says Jamie Justice, a doctor and executive director for the contest, which was bankrolled by Saudi Arabia\u2019s <a href=\"https:\/\/www.technologyreview.com\/2022\/06\/07\/1053132\/saudi-arabia-slow-aging-metformin\/\">Hevolution Foundation,<\/a> \u201cBut it will be incredibly hard to even get to one winner.\u201d<\/p>\n<p>Justice says a judging panel is now in the process of picking 10 finalists from 65 teams that have been exploring health foods, lifestyle interventions, digital trackers, and drug compounds.\u00a0<\/p>\n<p>Sinclair\u2019s team, Justice says, was a late entrant to the contest, but like all teams, it would be required to move into wider human tests starting this year. \u201cYou have to be ready and in trials,\u201d she says.<\/p>\n<p>The race to harness the reprogramming phenomenon and apply it to living people is heating up, even outside the XPrize competition. On June 2, a startup called NewLimit, founded by the crypto billionaire Brian Armstrong, said it had raised <a href=\"https:\/\/blog.newlimit.com\/p\/newlimit-raises-435m-led-by-founders\">a further $435 million<\/a>, from investors including Peter Thiel\u2019s Founders Fund, to support what it calls \u201cage reprogramming.\u201d\u00a0<\/p>\n<p>The company says it is working toward delivering genetic reprogramming instructions to the liver, to treat diseases of that organ.<\/p>\n<p>But Sinclair has been saying that whole-body rejuvenation is a possibility too. And for that, chemicals, rather than gene therapy, could be the most practical strategy.\u00a0<\/p>\n<p>Sinclair says his lab has been searching for such compounds and is starting to use AI \u201cto improve the oral agents that we\u2019re testing.\u201d<\/p>\n<p>Chemical reprogramming cocktails, as used in labs, typically involve a mix of vitamins, approved drugs, and experimental molecules. For instance, one recipe Sinclair filed a patent on includes the supplement forskolin,\u00a0 the antidepressant tranylcypromine, and an experimental chemical, laduviglusib, which has been tested against Alzheimer\u2019s, among other ingredients.<\/p>\n<p>\u201cIn those days it was a six-factor cocktail,\u201d Sinclair says of his earlier research. \u201cBut we\u2019ve come a long way. I can\u2019t disclose what\u2019s in it, but it\u2019s an improvement and an advance on that, and we\u2019ve done a number of animal studies. They are not published, but we\u2019ve been doing them for a long time, and we want to make sure that we\u2019ve done a full investigation of safety and efficacy before we release any of the data.\u201d<\/p>\n<p>While Sinclair\u2019s results aren\u2019t published, other teams say attempts to reverse the age of entire animals using chemical drugs haven\u2019t worked yet. Last year, the lab of Vadim Gladyshev, another Harvard biologist and a member of a different XPrize team, reported on its attempt to rejuvenate mice by installing pumps in their bodies that released controlled doses of seven compounds.<\/p>\n<p>Gladyshev says the procedure <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40667171\/\">proved to be toxic<\/a>. \u201cThe idea was to see if we could rejuvenate whole animals. Unfortunately, we have not found [the right] conditions,\u201d he says. \u201cAt low concentrations there was no effect, and high concentrations were toxic.\u201d <\/p>\n<p>Gladyshev says he doesn\u2019t know what is in Sinclair\u2019s cocktail, but says that \u201ctrying to improve the combinations makes sense.\u201d<\/p>\n<p>Sinclair, who is the author of several books on aging and has a large social media following, has frequently been criticized by other scientists for making unproven rejuvenation claims.\u00a0<\/p>\n<p>In 2024, he <a href=\"https:\/\/x.com\/NirBarzilaiMD\/status\/1767981636405043227\">resigned<\/a> as president of the Academy for Health and Lifespan Research after claiming that a supplement developed by a company his brother runs had \u201creversed\u201d the age of dogs, a claim for which there was so little evidence that one scientist called it a \u201c<a href=\"https:\/\/x.com\/mkaeberlein\/status\/1763430452457775491\">lie<\/a>.\u201d<\/p>\n<p>Part of the problem is that scientists still disagree on how to measure aging. And they don\u2019t have a reliable way to measure age reversal, either, should it ever be achieved.<\/p>\n<p>Justice, the XPRIZE director, says a primary purpose of the competition is to solve that problem by encouraging the development of standardized measures of aging. That is so that anti-aging drugs can be assessed reliably, and, one-day, approved by regulators if they work.<\/p>\n<p>\u00a0\u201cWe as a scientific field have been forced to ask, \u2018If a medicine improves how we age, how would we know?\u201d Justice said during <a href=\"https:\/\/youtu.be\/69XlKdbI4ug?t=2240\">a public meeting with FDA officials in May<\/a>. \u201cIf something worked, what would convince us as scientists, what\u2019s meaningful to the general public?\u201d<\/p>\n<p>Finalists in the Healthspan competition will be announced in August.<\/p>","protected":false},"excerpt":{"rendered":"<p>The outspoken longevity scientist David Sinclair has been predicting that one day, you\u2019ll go to the doctor and get a prescription that will make you 10 years younger. Now MIT Technology Review has learned that he has plans to launch human tests of an oral \u201creprogramming\u201d drug as part of a $101 million competition organized by the XPrize Foundation.\u00a0 The foundation is offering cash awards to teams able to \u201crestore\u201d a person to an earlier apparent age, as measured by improvements in immune, cognitive, and muscle function.\u00a0 The grand prize goes to any team able to show a 10-year (or greater) relative improvement after one year of treatment.\u00a0 Reached by phone, Sinclair, a biologist at Harvard Medical School, confirmed that he plans to give an oral drug mixture to volunteers in a bid to seek \u201cevidence for age restoration in humans.\u201d The trial, if it goes forward, will be a significant new development in the race to harness so-called epigenetic reprogramming. That technology is based on the discovery, 20 years ago, of powerful genes able to turn an adult cell into a stem cell similar to those found in embryos. The age-reversal effect is believed to occur via a resetting of molecular controls on DNA known as epigenetic marks, which help determine a cell\u2019s overall metabolism and identity. Companies are now racing to use that phenomenon for a new form of rejuvenation medicine. Only this January, one of Sinclair\u2019s companies, Life Biosciences, made news by winning approval to launch an initial human trial using a set of powerful reprogramming genes. The company announced today it had treated its first patient.\u00a0 But that test involves a complex gene therapy and is limited to patients\u2019 eyes, where it could treat conditions like glaucoma.\u00a0 Sinclair\u2019s new plan is bolder: a reprogramming drug you\u2019d swallow in order to promote such effects across the body.\u00a0 \u201cWhat we\u2019re aiming to do is to epigenetically restore the animal and eventually the person,\u201d he says. \u201cIt is true that we\u2019ve been doing extensive animal studies with the oral agent and are looking to compete in the XPrize.\u201d This alternative method, chemical reprogramming, uses drugs to mimic the effects of the embryonic genes. That is significant because drug compounds can travel through the bloodstream, reaching most or all cells in a person\u2019s body.\u00a0 Some experts expressed caution, saying the chemical process, at least as used in labs, is extremely harsh and not even particularly effective. \u201cWho doesn\u2019t dream of whole-body rejuvenation? I think it\u2019s a great goal,\u201d says Sergiy Velychko, founder of Soxogen, a stealth reprogramming company in Boston. \u201cBut these chemicals are used in very, very high concentrations for cell reprogramming.\u201d Sinclair declined to describe the exact makeup of the drug candidate, code-named SL-100, calling its contents \u201chighly, highly confidential.\u201d However, he has previously published lab studies of what he called \u201cepigenetic age-reversal cocktails,\u201d which mixed powerful chemicals with known supplements and commercially available medicines.\u00a0 It\u2019s those latter components that would be easiest to test on people, since doctors are free to prescribe them, even for unusual objectives like age reversal. James Clement, head of Betterhumans, an organization that specializes in life-extension studies using existing drugs, said in a message that he is \u201crunning clinical trials\u201d of an oral reprogramming cocktail for Sinclair\u2019s XPrize team. Sinclair\u2019s team is competing in the XPrize Healthspan Competition, launched in 2023. It follows several previous competitions that focused on commercial spaceflight, lunar landings, and other goals. The XPrize Foundation is led by executive chairman Peter Diamandis, also an active promoter of longevity research. \u201cIf two teams are equivalent, they would split the award,\u201d says Jamie Justice, a doctor and executive director for the contest, which was bankrolled by Saudi Arabia\u2019s Hevolution Foundation, \u201cBut it will be incredibly hard to even get to one winner.\u201d Justice says a judging panel is now in the process of picking 10 finalists from 65 teams that have been exploring health foods, lifestyle interventions, digital trackers, and drug compounds.\u00a0 Sinclair\u2019s team, Justice says, was a late entrant to the contest, but like all teams, it would be required to move into wider human tests starting this year. \u201cYou have to be ready and in trials,\u201d she says. The race to harness the reprogramming phenomenon and apply it to living people is heating up, even outside the XPrize competition. On June 2, a startup called NewLimit, founded by the crypto billionaire Brian Armstrong, said it had raised a further $435 million, from investors including Peter Thiel\u2019s Founders Fund, to support what it calls \u201cage reprogramming.\u201d\u00a0 The company says it is working toward delivering genetic reprogramming instructions to the liver, to treat diseases of that organ. But Sinclair has been saying that whole-body rejuvenation is a possibility too. And for that, chemicals, rather than gene therapy, could be the most practical strategy.\u00a0 Sinclair says his lab has been searching for such compounds and is starting to use AI \u201cto improve the oral agents that we\u2019re testing.\u201d Chemical reprogramming cocktails, as used in labs, typically involve a mix of vitamins, approved drugs, and experimental molecules. For instance, one recipe Sinclair filed a patent on includes the supplement forskolin,\u00a0 the antidepressant tranylcypromine, and an experimental chemical, laduviglusib, which has been tested against Alzheimer\u2019s, among other ingredients. \u201cIn those days it was a six-factor cocktail,\u201d Sinclair says of his earlier research. \u201cBut we\u2019ve come a long way. I can\u2019t disclose what\u2019s in it, but it\u2019s an improvement and an advance on that, and we\u2019ve done a number of animal studies. They are not published, but we\u2019ve been doing them for a long time, and we want to make sure that we\u2019ve done a full investigation of safety and efficacy before we release any of the data.\u201d While Sinclair\u2019s results aren\u2019t published, other teams say attempts to reverse the age of entire animals using chemical drugs haven\u2019t worked yet. Last year, the lab of Vadim Gladyshev, another Harvard biologist and a member of a different XPrize team, reported on its attempt to<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_pvb_checkbox_block_on_post":false,"footnotes":""},"categories":[52,5,7,1],"tags":[],"class_list":["post-96236","post","type-post","status-publish","format-standard","hentry","category-ai-club","category-committee","category-news","category-uncategorized","pmpro-has-access"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition - YouZum<\/title>\n<meta name=\"description\" content=\"\u0e01\u0e34\u0e08\u0e01\u0e23\u0e23\u0e21\u0e40\u0e01\u0e35\u0e48\u0e22\u0e27\u0e01\u0e31\u0e1a\u0e42\u0e14\u0e23\u0e19\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/youzum.net\/es\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition - YouZum\" \/>\n<meta property=\"og:description\" content=\"\u0e01\u0e34\u0e08\u0e01\u0e23\u0e23\u0e21\u0e40\u0e01\u0e35\u0e48\u0e22\u0e27\u0e01\u0e31\u0e1a\u0e42\u0e14\u0e23\u0e19\" \/>\n<meta property=\"og:url\" content=\"https:\/\/youzum.net\/es\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/\" \/>\n<meta property=\"og:site_name\" content=\"YouZum\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DroneAssociationTH\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-09T17:45:49+00:00\" \/>\n<meta name=\"author\" content=\"admin NU\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin NU\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/\"},\"author\":{\"name\":\"admin NU\",\"@id\":\"https:\/\/yousum.gpucore.co\/#\/schema\/person\/97fa48242daf3908e4d9a5f26f4a059c\"},\"headline\":\"David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition\",\"datePublished\":\"2026-06-09T17:45:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/\"},\"wordCount\":1318,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/yousum.gpucore.co\/#organization\"},\"articleSection\":[\"AI\",\"Committee\",\"News\",\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/\",\"url\":\"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/\",\"name\":\"David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition - YouZum\",\"isPartOf\":{\"@id\":\"https:\/\/yousum.gpucore.co\/#website\"},\"datePublished\":\"2026-06-09T17:45:49+00:00\",\"description\":\"\u0e01\u0e34\u0e08\u0e01\u0e23\u0e23\u0e21\u0e40\u0e01\u0e35\u0e48\u0e22\u0e27\u0e01\u0e31\u0e1a\u0e42\u0e14\u0e23\u0e19\",\"breadcrumb\":{\"@id\":\"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/youzum.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/yousum.gpucore.co\/#website\",\"url\":\"https:\/\/yousum.gpucore.co\/\",\"name\":\"YouSum\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/yousum.gpucore.co\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/yousum.gpucore.co\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/yousum.gpucore.co\/#organization\",\"name\":\"Drone Association Thailand\",\"url\":\"https:\/\/yousum.gpucore.co\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/yousum.gpucore.co\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/youzum.net\/wp-content\/uploads\/2024\/11\/tranparent-logo.png\",\"contentUrl\":\"https:\/\/youzum.net\/wp-content\/uploads\/2024\/11\/tranparent-logo.png\",\"width\":300,\"height\":300,\"caption\":\"Drone Association Thailand\"},\"image\":{\"@id\":\"https:\/\/yousum.gpucore.co\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/DroneAssociationTH\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/yousum.gpucore.co\/#\/schema\/person\/97fa48242daf3908e4d9a5f26f4a059c\",\"name\":\"admin NU\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/yousum.gpucore.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/youzum.net\/wp-content\/uploads\/avatars\/2\/1746849356-bpfull.png\",\"contentUrl\":\"https:\/\/youzum.net\/wp-content\/uploads\/avatars\/2\/1746849356-bpfull.png\",\"caption\":\"admin NU\"},\"url\":\"https:\/\/youzum.net\/es\/members\/adminnu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition - YouZum","description":"\u0e01\u0e34\u0e08\u0e01\u0e23\u0e23\u0e21\u0e40\u0e01\u0e35\u0e48\u0e22\u0e27\u0e01\u0e31\u0e1a\u0e42\u0e14\u0e23\u0e19","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/youzum.net\/es\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/","og_locale":"es_ES","og_type":"article","og_title":"David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition - YouZum","og_description":"\u0e01\u0e34\u0e08\u0e01\u0e23\u0e23\u0e21\u0e40\u0e01\u0e35\u0e48\u0e22\u0e27\u0e01\u0e31\u0e1a\u0e42\u0e14\u0e23\u0e19","og_url":"https:\/\/youzum.net\/es\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/","og_site_name":"YouZum","article_publisher":"https:\/\/www.facebook.com\/DroneAssociationTH\/","article_published_time":"2026-06-09T17:45:49+00:00","author":"admin NU","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admin NU","Tiempo de lectura":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/#article","isPartOf":{"@id":"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/"},"author":{"name":"admin NU","@id":"https:\/\/yousum.gpucore.co\/#\/schema\/person\/97fa48242daf3908e4d9a5f26f4a059c"},"headline":"David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition","datePublished":"2026-06-09T17:45:49+00:00","mainEntityOfPage":{"@id":"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/"},"wordCount":1318,"commentCount":0,"publisher":{"@id":"https:\/\/yousum.gpucore.co\/#organization"},"articleSection":["AI","Committee","News","Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/","url":"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/","name":"David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition - YouZum","isPartOf":{"@id":"https:\/\/yousum.gpucore.co\/#website"},"datePublished":"2026-06-09T17:45:49+00:00","description":"\u0e01\u0e34\u0e08\u0e01\u0e23\u0e23\u0e21\u0e40\u0e01\u0e35\u0e48\u0e22\u0e27\u0e01\u0e31\u0e1a\u0e42\u0e14\u0e23\u0e19","breadcrumb":{"@id":"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/youzum.net\/david-sinclair-plans-to-test-whole-body-rejuvenation-drugs-in-the-xprize-competition\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/youzum.net\/"},{"@type":"ListItem","position":2,"name":"David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition"}]},{"@type":"WebSite","@id":"https:\/\/yousum.gpucore.co\/#website","url":"https:\/\/yousum.gpucore.co\/","name":"YouSum","description":"","publisher":{"@id":"https:\/\/yousum.gpucore.co\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/yousum.gpucore.co\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/yousum.gpucore.co\/#organization","name":"Drone Association Thailand","url":"https:\/\/yousum.gpucore.co\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/yousum.gpucore.co\/#\/schema\/logo\/image\/","url":"https:\/\/youzum.net\/wp-content\/uploads\/2024\/11\/tranparent-logo.png","contentUrl":"https:\/\/youzum.net\/wp-content\/uploads\/2024\/11\/tranparent-logo.png","width":300,"height":300,"caption":"Drone Association Thailand"},"image":{"@id":"https:\/\/yousum.gpucore.co\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/DroneAssociationTH\/"]},{"@type":"Person","@id":"https:\/\/yousum.gpucore.co\/#\/schema\/person\/97fa48242daf3908e4d9a5f26f4a059c","name":"admin NU","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/yousum.gpucore.co\/#\/schema\/person\/image\/","url":"https:\/\/youzum.net\/wp-content\/uploads\/avatars\/2\/1746849356-bpfull.png","contentUrl":"https:\/\/youzum.net\/wp-content\/uploads\/avatars\/2\/1746849356-bpfull.png","caption":"admin NU"},"url":"https:\/\/youzum.net\/es\/members\/adminnu\/"}]}},"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"admin NU","author_link":"https:\/\/youzum.net\/es\/members\/adminnu\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/youzum.net\/es\/category\/ai-club\/\" rel=\"category tag\">AI<\/a> <a href=\"https:\/\/youzum.net\/es\/category\/committee\/\" rel=\"category tag\">Committee<\/a> <a href=\"https:\/\/youzum.net\/es\/category\/news\/\" rel=\"category tag\">News<\/a> <a href=\"https:\/\/youzum.net\/es\/category\/uncategorized\/\" rel=\"category tag\">Uncategorized<\/a>","rttpg_excerpt":"The outspoken longevity scientist David Sinclair has been predicting that one day, you\u2019ll go to the doctor and get a prescription that will make you 10 years younger. Now MIT Technology Review has learned that he has plans to launch human tests of an oral \u201creprogramming\u201d drug as part of a $101 million competition organized&hellip;","_links":{"self":[{"href":"https:\/\/youzum.net\/es\/wp-json\/wp\/v2\/posts\/96236","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/youzum.net\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/youzum.net\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/youzum.net\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/youzum.net\/es\/wp-json\/wp\/v2\/comments?post=96236"}],"version-history":[{"count":0,"href":"https:\/\/youzum.net\/es\/wp-json\/wp\/v2\/posts\/96236\/revisions"}],"wp:attachment":[{"href":"https:\/\/youzum.net\/es\/wp-json\/wp\/v2\/media?parent=96236"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/youzum.net\/es\/wp-json\/wp\/v2\/categories?post=96236"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/youzum.net\/es\/wp-json\/wp\/v2\/tags?post=96236"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}